US Senators urge FTC to closely scrutinise pharma mergers

19-09-2019

Saman Javed

US Senators urge FTC to closely scrutinise pharma mergers

Mark Van Scyoc / Shutterstock.com

A group of senators has urged the US Federal Trade Commission (FTC) to closely scrutinise mergers in the pharmaceutical industry, which it said “increase competition issues and stifle innovation”.


AbbVie, Allergan, US Federal Trade Commission, mergers and acquisitions, Amy Klobucher

More on this story

AbbVie to acquire Allergan for $63bn
25-06-2019

LSIPR